Clinical Trials Logo

Cancer Pain clinical trials

View clinical trials related to Cancer Pain.

Filter by:

NCT ID: NCT00930332 Terminated - Pain Clinical Trials

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Start date: June 17, 2010
Phase: Phase 1
Study type: Interventional

RATIONALE: Methadone hydrochloride may reduce chronic neuropathic pain in patients with cancer. PURPOSE: This phase I trial is studying the side effects and best dose of methadone hydrochloride as first-line therapy in treating patients with chronic neuropathic cancer pain.

NCT ID: NCT00842829 Terminated - Cancer Pain Clinical Trials

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Start date: January 2009
Phase: Phase 4
Study type: Interventional

Breakthrough cancer pain (BTcP) is a common problem in patients with cancer. Fentanyl Buccal Tablet (FBT) is used for the treatment of BTP in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. FBT treatment should be individually titrated to an effective dose that provides adequate analgesia and minimizes undesirable effects. To reach the safest effective dose for the individual patient as soon as possible, the dose titration process is critical. The aim of this study, conducted under pragmatic conditions in a large-scale population of cancer patients is to compare the proportion of patients reaching an effective FBT dose after titration starting with either a 100 mcg dose or a 200 mcg dose.

NCT ID: NCT00804076 Completed - Cancer Pain Clinical Trials

Gene Transfer for Cancer Pain

Start date: February 2008
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to examine the safety of NP2 (a nonreplicating HSV-based vector expressing enkephalin) in patients with cancer pain. The secondary purpose is to evaluate efficacy.

NCT ID: NCT00803283 Terminated - Cancer Pain Clinical Trials

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of Osmotic Release Oral System (OROS) hydromorohone Hydrochloride (HCl) compared with morphine sustain release (SR) in participants with chronic (lasting a long time) malignant (cancerous) cancer pain.

NCT ID: NCT00771199 Completed - Cancer, Pain Clinical Trials

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate safety/tolerability and clinical utility of low-dose transdermal therapeutic system (TTS [medicated adhesive pad that is placed on the skin to deliver a timed-release dose of medication through the skin into the bloodstream]) - fentanyl in Taiwan participants with cancer pain. Secondly, to demonstrate the dropout rate that will be decreased by initiating therapy with12 microgram per hour (mcg/hr) instead of with 25 mcg/h.

NCT ID: NCT00766831 Completed - Cancer Pain Clinical Trials

An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this is study to evaluate improvement of sleep disorder caused by cancer pain after the administration of Hydromorphone Oral Osmotic System (OROS) in Korean participants with cancer.

NCT ID: NCT00684632 Completed - Pain, Cancer Clinical Trials

A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

Start date: March 2008
Phase: Phase 3
Study type: Interventional

This study is designed to determine whether KW-2246 is superior to placebo and not inferior to immediate-release morphine for the relief of breakthrough pain in cancer patients.

NCT ID: NCT00683995 Completed - Pain, Cancer Clinical Trials

A Phase III Clinical Study of KW-2246

Start date: March 2008
Phase: Phase 3
Study type: Interventional

This study is designed to assess the safety and efficacy of long-term KW-2246 treatment as rescue medication for breakthrough pain.

NCT ID: NCT00676936 Completed - Pain Clinical Trials

Corticosteroids for Cancer Pain

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Study hypothesis: corticosteroids are effective for pain in cancer patients. We will perform a double-blind, randomized, placebo-controlled multicentre trial evaluating the effect of Methylprednisolone 16 mg twice daily in cancer patients with pain (average pain last 24 hrs NRS > 4 (Numerical rating scale, 0 No pain, 10 worst pain).

NCT ID: NCT00675948 Completed - Pain Clinical Trials

Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

Start date: April 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® and GW-2000-02.